相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis
Anne Fogli et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
Emeline Tabouret et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri et al.
GENOME MEDICINE (2016)
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller et al.
ACTA NEUROPATHOLOGICA (2015)
Molecular Pathways: Targeting ATR in Cancer Therapy
Larry M. Karnitz et al.
CLINICAL CANCER RESEARCH (2015)
Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells
Rita Eid et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
Hilda A. Pickett et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Rachel Litman Flynn et al.
SCIENCE (2015)
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX
David Clynes et al.
NATURE COMMUNICATIONS (2015)
Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
Hilda A. Pickett et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
ATRX represses alternative lengthening of telomeres
Christine E. Napier et al.
ONCOTARGET (2015)
A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)
Maya Jeitany et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
ALTernative Telomere Maintenance and Cancer
Robert L. Dilley et al.
TRENDS IN CANCER (2015)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer
Irena Draskovic et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations
Dominique Figarella-Branger et al.
NEURO-ONCOLOGY (2014)
The Definition of Primary and Secondary Glioblastoma
Hiroko Ohgaki et al.
CLINICAL CANCER RESEARCH (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas
Ahmed Idbaih et al.
PLOS ONE (2012)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Jeremy D. Henson et al.
NATURE BIOTECHNOLOGY (2009)
A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT
MA Cerone et al.
ONCOGENE (2005)
A novel telomere structure in a human alternative lengthening of telomeres cell line
RA Marciniak et al.
CANCER RESEARCH (2005)
Merase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies
CL Fasching et al.
CANCER RESEARCH (2005)
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
V Hakin-Smith et al.
LANCET (2003)
分享论文
